Evaluation of analgesic and anti-inflammatory activities of the root extract of Grewia schweinfurthii Burret and its major chemical constituents

Despite the widespread use of conventional analgesic and anti-inflammatory drugs, their clinical utility is often limited by adverse effects, necessitating the search for safer alternatives from medicinal plants. This study investigated the analgesic and anti-inflammatory activities of the 80% methanolic root extract of Grewia schweinfurthii Burret and an isolated bioactive compound using established rodent models. Air-dried roots were extracted by maceration with 80% methanol, and acute oral toxicity was evaluated following OECD guidelines. Analgesic activity was assessed using the acetic acid–induced writhing and hot plate models in mice, while anti-inflammatory activity was evaluated using carrageenan-induced paw edema in rats. A bioactive compound, 4 (2ʺ-(4′-isopropylphenyl) propan-2ʺ-yl)-2,3-dihydrofuran, was isolated via column chromatography and tested for anti-inflammatory activity. In the writhing test, the extract produced significant (p < 0.001) dose-dependent inhibition of abdominal constrictions, with 13.90%, 56.81%, and 75.48% inhibition at 100, 200, and 400 mg/kg, respectively, compared to 80.77% inhibition by aspirin (150 mg/kg). In the hot plate model, the 400 mg/kg dose significantly prolonged latency time from a baseline of 5.67 ± 0.33 s to 9.17 ± 1.01 s at 120 min (p < 0.05), indicating central analgesic activity. In the carrageenan-induced paw edema model, the extract demonstrated marked anti-inflammatory effects, with 93% inhibition at 400 mg/kg at the 5th hour, comparable to indomethacin (95% inhibition). The isolated compound exhibited significant dose-dependent anti-inflammatory activity, achieving 75% inhibition at 40 mg/kg at 5 hours (p < 0.001). Overall, the findings demonstrate that G. schweinfurthii root extract and its isolated compound possess significant peripheral and central analgesic as well as potent anti-inflammatory activities, supporting the plant’s traditional use; however, further mechanistic, toxicological, and pharmacokinetic studies are required before clinical relevance can be established.

Authors

Publication Details

Journal
PLoS ONE
Published
2026-07-22
DOI
https://doi.org/10.1371/journal.pone.0353400
Primary Topic
African Botany and Ecology Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of analgesic and anti-inflammatory activities of the root extract of Grewia schweinfurthii Burret and its major chemical constituents

Solomon Tadesse, Mirutse Giday, Ariaya Hymete, Abdi Leta Gemechu
PLoS ONE
African Botany and Ecology Studies
article

Evaluation of analgesic and anti-inflammatory activities of the root extract of Grewia schweinfurthii Burret and its major chemical constituents

Solomon Tadesse, Mirutse Giday, Ariaya Hymete, Abdi Leta Gemechu
article en

Abstract

Despite the widespread use of conventional analgesic and anti-inflammatory drugs, their clinical utility is often limited by adverse effects, necessitating the search for safer alternatives from medicinal plants. This study investigated the analgesic and anti-inflammatory activities of the 80% methanolic root extract of Grewia schweinfurthii Burret and an isolated bioactive compound using established rodent models. Air-dried roots were extracted by maceration with 80% methanol, and acute oral toxicity was evaluated following OECD guidelines. Analgesic activity was assessed using the acetic acid–induced writhing and hot plate models in mice, while anti-inflammatory activity was evaluated using carrageenan-induced paw edema in rats. A bioactive compound, 4 (2ʺ-(4′-isopropylphenyl) propan-2ʺ-yl)-2,3-dihydrofuran, was isolated via column chromatography and tested for anti-inflammatory activity. In the writhing test, the extract produced significant (p < 0.001) dose-dependent inhibition of abdominal constrictions, with 13.90%, 56.81%, and 75.48% inhibition at 100, 200, and 400 mg/kg, respectively, compared to 80.77% inhibition by aspirin (150 mg/kg). In the hot plate model, the 400 mg/kg dose significantly prolonged latency time from a baseline of 5.67 ± 0.33 s to 9.17 ± 1.01 s at 120 min (p < 0.05), indicating central analgesic activity. In the carrageenan-induced paw edema model, the extract demonstrated marked anti-inflammatory effects, with 93% inhibition at 400 mg/kg at the 5th hour, comparable to indomethacin (95% inhibition). The isolated compound exhibited significant dose-dependent anti-inflammatory activity, achieving 75% inhibition at 40 mg/kg at 5 hours (p < 0.001). Overall, the findings demonstrate that G. schweinfurthii root extract and its isolated compound possess significant peripheral and central analgesic as well as potent anti-inflammatory activities, supporting the plant’s traditional use; however, further mechanistic, toxicological, and pharmacokinetic studies are required before clinical relevance can be established.

PLoS ONEVol. 21(7)
Openalex Percentile: Top 4%
African Botany and Ecology Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.